The efficacy of selective serotonin reuptake inhibitors for the management of chronic pain

Journal of General Internal Medicine

Volumn 12, Issue 6, 1997, Pages 384-389

  Jung, Alan C ^a   Staiger, Thomas ^a   Sullivan, Mark ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Chronic pain, management of; Selective serotonin reuptake inhibitors

Indexed keywords

AMITRIPTYLINE; CITALOPRAM; FEMOXETINE; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; PAROXETINE; PROPRANOLOL; SEROTONIN UPTAKE INHIBITOR; SULPIRIDE; TRICYCLIC ANTIDEPRESSANT AGENT; ZIMELDINE;

CHRONIC PAIN; CLINICAL TRIAL; DIABETIC NEUROPATHY; DRUG EFFICACY; DRUG INDICATION; DRUG TOLERABILITY; FIBROMYALGIA; HEADACHE; HUMAN; META ANALYSIS; MIGRAINE; PATIENT SELECTION; REVIEW; TENSION HEADACHE; TREATMENT INDICATION; TREATMENT OUTCOME;

CHRONIC DISEASE; DIABETIC NEUROPATHIES; FIBROMYALGIA; HEADACHE; HUMANS; PAIN; RANDOMIZED CONTROLLED TRIALS; SEROTONIN UPTAKE INHIBITORS;

EID: 0030906658     PISSN: 08848734     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11606-006-5088-3     Document Type: Review

References (33)

1. Nachemson AL. Newest knowledge of low back pain: a critical look. Clin Orthop. 1992;279:8-20.
2. Chabal C, Jacobsen L, Chaney EF, Mariano AJ. Narcotic for chronic pain: yes or no? A useless dichotomy. APS J. 1992;1:276-81.
3. Onghena P, Van Houdenhove B. Antidepressant-induced analgesia in chronic non-malignant pain: a meta-analysis of 39 placebo controlled studies. Pain. 1992;49:205-9.
4. Olfson M, Klerman G. Trends in prescription of antidepressants by office-based psychiatrists. Am J Psychiatry. 1993;150:571-7.
5. Broadhead WE, Larson DB, Yarnall KSH, Blazer DG, Tse CKJ. Tricyclic antidepressant prescribing for nonpsychiatric disorders. J Fam Pract. 1991;33:24-32.
6. Saper JR, Silberstein SD, Lake AE 3rd, Winters ME. Double-blind trial of fluoxetine: chronic daily headache and migraine. Headache. 1994;34:497-502.
7. Langemark M, Olesen J. Sulpiride and paroxetine in the treatment of chronic tension-type headache. An explanatory double-blind trial. Headache. 1994;34:20-4.
8. Manna V, Bolino F, Di Cicco L. Chronic tension-type headache, mood, depression and serotonin: therapeutic effects of fluvoxamine and minanserine. Headache. 1994;34:44-9.
9. Bendtsen L, Jensen R, Olesen J. A non-selective (amitriptyline), but not a selective (citalopram). serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension-type headache. J Neurol Neurosurg Psychiatry. 1996;61:285-90.
10. Andersson PG, Petersen EN. Propranolol and femoxetine, a 5 HT-uptake inhibitor, in migraine prophylaxis. A double-blind crossover study. Acta Neurol Scand. 1981;64:280-8.
11. Zeeberg I, Orholm M, Nielsen JD, et al. Femoxetine in the prophylaxis of migraine - a randomised comparison with placebo. Acta Neurol Scand. 1981;64:452-9.
12. Orholm M, Honoré PF, Zeeberg I. A randomized general practice group - comparative study of femoxetine and placebo in the prophylaxis of migraine. Acta Neurol Scand. 1986;74:235-9.
13. Kangasniemi PJ, Nyrke T, Lang AH, Petersen E. Femoxetine - a new 5 HT uptake inhibitor - and propranolol in the prophylactic treatment of migraine. Acta Neurol Scand. 1983;68:262-7.
14. Adly CA, Straumanis J, Chesson A. Fluoxetine prophylaxis of migraine. Headache. 1992;32:101-4.
15. Bank J. A comparative study of amitriptyline and fluvoxamine in migraine prophylaxis. Headache. 1994;34:476-8.
16. Max MB, Lynch SA, Muir J, Shoaf SE, Smoller B, Dubner R. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med. 1992;326:1250-6.
17. Sindrup SH, Gram LF, Brosen K, Eshoj O, Mogensen EF. The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain. 1990;42:135-44.
18. Sindrup SH, Grodum E, Gram LF, Beck-Nielsen H. Concentration-response relationship in paroxetine treatment of diabetic neuropathy symptoms: a patient-blinded dose-escalation study. Ther Drug Monit. 1991;13:408-14.
19. Sindrup SH, Bjerre U, Dejgaard A, Brosen K, Aaes-Jorgensen T, Gram LF. The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy. Clin Pharmacol Ther. 1992;52:547-52.
20. Wolfe F, Cathey MA, Hawley DJ. A double-blind placebo controlled trial of fluvoxamine in fibromyalgia. Scand J Rheumatol. 1994; 23:255-9.
21. Goldenberg DL, Mayskly M, Mossey C, et al. A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia. Arthritis Rheum. 1996;39(11):1852-9.
22. Norregaard J, Volkmann H, Danneskiold-Samsoe B. A randomized controlled trial of citalopram in the treatment of fibromyalgia. Pain. 1995;61:445-9.
23. Johansson F, Knorring LV. A double-blind controlled study of a serotonin uptake inhibitor (zimelidine) versus placebo in chronic pain patients. Pain. 1979;7:69-78.
24. Gourlay GK, Cherry DA, Cousins MJ, et al. A controlled study of a serotonin reuptake blocker, zimelidine, in the treatment of chronic pain. Pain. 1986;25:35-52.
25. Usha Rani P, Naidu MUR, Prasad VBN, et al. An evaluation of antidepressants in rheumatic pain conditions. Anesth Analg. 1996; 83:371-5.
26. Saper JR, Silberstein SD, Lake AE 3rd, Winters ME. Fluoxetine and migraine: comparison of double-blind trials. Headache. 1995;35:233. Letter.
27. Cohn CK, Mendels J, Cohn JB, et al. Double-blind, multicenter comparison of sertraline and amitriptyline in elderly depressed patients. J Clin Psychiatry. 1990;51(suppl):28-33.
28. Heiligenstein JH, Ware JE, Beuerstein KM, Roback PJ, Andrejasich C, Tollefson GD. Acute effects of fluoxetine versus placebo on functional status and well-being in late-life depression. Int Psychogeriatr. 1995;7(suppl): 125-37.
29. Max MB. Treatment of post-herpetic neuralgia: antidepressants. Ann Neurol. 1994;35(suppl):S50-3.
30. Ardid D, Marty H, Fialip J, Eschalier A, Levarenne J. Comparative effects of different uptake inhibitor antidepressants in two pain tests in mice. Fundam Clin Pharmacol. 1992;6:75-82.
31. Reddy SVR, Maderut JL, Yaksh TL. Spinal cord pharmacology of adrenergic agonist-mediated antinociception. J Pharmacol Exp Ther. 1990;213:525-33.
32. Eide PK, Hole K. Different role of 5HT-1A and 5HT2 receptors in spinal cord in control of nociceptive responsiveness. Neuropharmacology. 1991;30:727-31.
33. Songer DA, Schulte H. Venlafaxine for chronic pain. Am J Psychiatry. 1996;153:737. Letter.